A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population

被引：0
|
作者：
Jennifer Jewell
Joshua Black
Matthew Ellis
Heather Olsen
Janetta Iwanicki
Richard Dart
机构：
[1] Denver Health and Hospital Authority,Rocky Mountain Poison and Drug Safety
[2] Washington University in St. Louis,Department of Psychiatry, School of Medicine
来源：
Clinical Drug Investigation | 2023年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：197 / 203
页数：6
相关论文
共 38 条
  • [31] Response to Crudele et al. Commentary on Gudin et al. "Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties"
    Gudin, Jeff
    Kopecky, Ernest A.
    Fleming, Alison B.
    PAIN MEDICINE, 2017, 18 (05) : 992 - 994
  • [32] Relative bioavailability of naltrexone from crushed alo-01, an investigational extended-release, abuse-deterrent morphine sulfate formulation with sequestered naltrexone, compared with naltrexone solution.
    Johnson, F.
    Stark, J. G.
    Bieberdorf, F. A.
    Jones, J. B.
    Stauffer, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S28 - S28
  • [33] Evaluating the effectiveness of reformulated extended-release oxycodone with abuse-deterrent properties on reducing non-oral abuse among individuals assessed for substance abuse treatment with the Addiction Severity Index-Multimedia Version (ASI-MV)
    Rodriguez, Rachelle D.
    Govoni, Taryn Dailey
    Rajagopal, Venkat
    Green, Jody L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (04) : 579 - 587
  • [34] PERCEPTIONS OF EXTENDED-RELEASE BUPRENORPHINE INJECTIONS FOR OPIOID DEPENDENCE PRIOR TO AVAILABILITY IN AUSTRALIA: A CROSS-SECTIONAL SURVEY OF PEOPLE WHO USE OPIOIDS REGULARLY
    Larance, Briony
    Degenhardt, Louisa
    Grebely, Jason
    Nielsen, Suzanne
    Bruno, Raimondo
    Dietze, Paul M.
    Lancaster, Kari
    Larney, Sarah
    Santo, Thomas, Jr.
    Shanahan, Marian
    Memedovic, Sonja
    Ali, Robert
    Farrell, Michael
    DRUG AND ALCOHOL REVIEW, 2019, 38 : S63 - S64
  • [35] Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, Canada
    Iacono, Anita
    Wang, Tianru
    Tadrous, Mina
    Campbell, Tonya
    Kolla, Gillian
    Sproule, Beth
    Kleinman, Robert A.
    Besharah, Jes
    Munro, Charlotte
    Doolittle, Mccaffrey
    Gomes, Tara
    DRUG AND ALCOHOL DEPENDENCE, 2024, 254
  • [36] Predictors of Sexual Dysfunction in Women Seeking Treatment for Opioid Use Disorder: A Comparative Cross-Sectional Study from a Tertiary Center
    Saglam, Nazife Gamze Usta
    Ergelen, Mine
    Kilic, Muhsin Koray
    Bestepe, Engin Emrem
    Bilici, Rabia
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2023, 61 (05): : 358 - 365
  • [37] A single-center, randomized, double-blind crossover study to evaluate the abuse potential, pharmacokinetics, and safety of milled and intranasally administered extended-release hydrocodone (HYD) in recreational opioid users
    Harris, S.
    Colucci, S.
    Perrino, P.
    Kapil, R.
    Hopyan, T.
    Levy-Cooperman, N.
    Geoffroy, P.
    JOURNAL OF PAIN, 2014, 15 (04): : S86 - S86
  • [38] Clubfoot Deformity Treatment with Ilizarov Apparatus in the Paediatric Population without Corrective Osteotomies and Soft Tissue Release: A Cross-Sectional Study
    Aslani, H. S.
    Athari, M. B.
    Tavakoli-Darestani, R.
    Pourmojarab, A.
    Baroutkoub, M.
    Zamani, M.
    MALAYSIAN ORTHOPAEDIC JOURNAL, 2023, 17 (03) : 42 - 47
1234